Skip to main content

Advertisement

Log in

Efficacy of Local Control Strategies for Ewing Sarcoma After Neoadjuvant Chemotherapy: A Network Meta-analysis

  • Systamatic Review
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

This network meta-analysis aimed at comparing the efficacy of local control strategies after neoadjuvant chemotherapy in patients with Ewing sarcoma.

Design

Network meta-analysis was used to synthesize direct and indirect evidence in a network of trials that compare multiple interventions and has the potential to rank the competing treatments according to the studied outcome.

Setting

There are three treatment options for local Ewing’s sarcoma after neoadjuvant chemotherapy, namely surgery, radiotherapy and surgery plus radiotherapy (SR).

Participants

Records of 2540 patients from 11 studies were analyzed.

Main outcome measures

Potentially relevant studies were retrieved from PubMed and Embase, and screened according to inclusion and exclusion criteria. Hazard ratios and the associated 95% confidence intervals were used to describe the efficacy of different interventions on 5-year local recurrence rate and 5-year event-free survival rate. Surface under the cumulative ranking curve (SUCRA) was calculated for ranking probabilities of different treatment.

Results

Compared with radiotherapy, surgery had better efficacy [local recurrence, OR (95% CI) 0.48 (0.33–0.87)] and SR had a similar effect as surgery [local recurrence, OR (95% CI) 0.50 (0.29–0.82)]. There were no statistically significant differences between three different local control strategies in 5-year local recurrence rate. SUCRA values suggested that surgery was better than SR for 5-year local recurrence rate (0.79 vs 0.70) and 5-year event free survival rate (0.67 vs 0.50), respectively.

Conclusions

Both surgery and SR were superior to radiotherapy in reducing 5-yer local recurrence of patients with Ewing sarcoma after neoadjuvant chemotherapy. Surgery had higher efficacy than SR on improving the prognosis of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Werier J, Yao X, Caudrelier JM, Di Primio G, Ghert M, Gupta AA, et al. A systematic review of optimal treatment strategies for localized Ewing’s sarcoma of bone after neoadjuvant chemotherapy. Surg Oncol. 2016;25:16–23

    Article  Google Scholar 

  2. Bolling T, Hardes J, Dirksen U. Management of bone tumours in paediatric oncology. Clin Oncol (R Coll Radiol). 2013;25: 19–26.

    Article  CAS  Google Scholar 

  3. Moore DD, Haydon RC. Ewing’s sarcoma of bone. Cancer Treat Res. 2014;162: 93–115.

    Article  Google Scholar 

  4. Falk S, Alpert M. Five-year survival of patients with Ewing’s sarcoma. Surg Gynecol Obstet. 1967;124: 319–24.

    CAS  PubMed  Google Scholar 

  5. Pretz JL, Barysauskas CM, George S, Hornick JL, Raut CP, Chen YE, et al. Localized adult ewing sarcoma: Favorable outcomes with alternating vincristine, doxorubicin, cyclophosphamide, and ifosfamide, etoposide (VDC/IE)-based multimodality therapy. Oncologist. 2017;22: 1265–70.

    Article  CAS  Google Scholar 

  6. Wardelmann E, Haas R, Bovée J, Terrier P, Lazar A, Messiou C, et al. Evaluation of Response After Neoadjuvant Treatment in Soft Tissue Sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) Recommendations for Pathological Examination and Reporting. Eur J Cancer. 2016;53: 84–95.

    Article  CAS  Google Scholar 

  7. DuBois SG, Krailo MD, Gebhardt MC, Donaldson SS, Marcus KJ, Dormans J, et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children’s Oncology Group. Cancer. 2015;121: 467–75.

    Article  Google Scholar 

  8. Donati D, Yin J, Di Bella C, Colangeli M, Bacci G, Ferrari S, et al. Local and distant control in non-metastatic pelvic Ewing’s sarcoma patients. J Surg Oncol. 2007;96: 19–25.

    Article  Google Scholar 

  9. Ahmed SK, Randall RL, DuBois SG, Harmsen WS, Krailo M, Marcus KJ, et al. Identification of patients with localized Ewing sarcoma at higher risk for local failure: A report from the Children’s oncology group. Int J Radiat Oncol Biol Phys. 2017;99: 1286–94.

    Article  Google Scholar 

  10. Carrie C. Nonmetastatic Pelvic Ewing Sarcoma: Report of the French Society of Pediatric Oncology. Med Pediatr Oncol. 1999; 33:444–9

    Article  CAS  Google Scholar 

  11. De Marco S, Pollera CF, Cognetti F. Nephroblastoma in the adult. Med Pediatr Oncol. 1999;33: 497–9.

    Article  CAS  Google Scholar 

  12. Zogopoulos G, Teskey L, Sung L, Dix D, Grant R, Greenberg ML, et al. Ewing sarcoma: Favourable results with combined modality therapy and conservative use of radiotherapy. Pediatr Blood Cancer. 2004;43: 35–9.

    Article  Google Scholar 

  13. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. British Med J. 2011;343: d5928.

    Article  Google Scholar 

  14. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): Development and validation of a new instrument. ANZ J Surg. 2003;73: 712–6.

    Article  Google Scholar 

  15. Ahmed SK, Robinson SI, Arndt CAS, Petersen IA, Haddock MG, Rose PS, et al. Pelvis Ewing sarcoma: Local control and survival in the modern era. Pediatr Blood Cancer. 2017;64: e26504.

    Article  Google Scholar 

  16. Laitinen M, Parry M, Albergo JI, Jeys L, Sumathi V, Grimer R. Outcome of pelvic bone sarcomas in children. J Pediatr Orthop. 2016;38: 537–42.

    Article  Google Scholar 

  17. Grevener K, Haveman LM, Ranft A, van den Berg H, Jung S, Ladenstein R, et al. Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer. 2016;63: 604–10.

    Article  Google Scholar 

  18. Bacci G, Palmerini E, Staals EL, Longhi A, Barbieri E, Alberghini M, et al. Ewing’s sarcoma family tumors of the humerus: Outcome of patients treated with radiotherapy, surgery or surgery and adjuvant radiotherapy. Radiother Oncol. 2009;93: 383–7.

    Article  Google Scholar 

  19. Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, et al. Local control in pelvic Ewing sarcoma: analysis from INT-0091-A report from the Children’s Oncology Group. J Clin Oncol. 2006;24: 3838–43.

    Article  Google Scholar 

  20. Bacci G, Longhi A, Briccoli A, Bertoni F, Versari M, Picci P. The role of surgical margins in treatment of Ewing’s sarcoma family tumors: Experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65: 766–72.

    Article  Google Scholar 

  21. Shankar AG. Local therapy and other factors Infuencing site of relapse in patients with localised Ewing’s sarcoma. Eue J Cancer. 1999;35: 1698–1704.

    Article  CAS  Google Scholar 

  22. Sokolov T, Stoyanova A, Mumdjiev I, Mihova A. Comparison of two treatment approaches to localized Ewing’s sarcoma. Ortopediya i Travmatologiya. 2000;36: 509–15.

    Google Scholar 

  23. Shankar AG, Pinkerton CR, Atra A, Ashley S, Lewis I, Spooner D, et al. Local therapy and other factors influencing site of relapse in patients with localised Ewing’s sarcoma. United Kingdom Children’s Cancer Study Group (UKCCSG). Eur J Cancer. 1999;35: 1698–704.

    CAS  Google Scholar 

  24. Kawai A, Healey JH, Boland PJ, Lin PP, Huvos AG, Meyers PA. Prognostic factors for patients with sarcomas of the pelvic bones. Cancer. 1998;82: 851–9.

    Article  CAS  Google Scholar 

  25. Laitinen M, Parry M, Albergo JI, Jeys L, Sumathi V, Grimer R. Outcome of pelvic bone sarcomas in children. J Pediatr Orthop. 2018;38: 537–42.

    Article  Google Scholar 

  26. O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet. 2002;359:2235–41

    Article  Google Scholar 

  27. Foulon S, Brennan B, Gaspar N, Dirksen U, Jeys L, Cassoni A, et al. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-EWING group. Eur J Cancer. 2016;61: 128–36.

    Article  Google Scholar 

  28. Bacci G, Forni C, Longhi A, Ferrari S, Donati D, De Paolis M, et al. Long-term outcome for patients with non-metastatic Ewing’s sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004; 40:73–83.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

HZ,YL,XX: substantial contribution to the conception and design of the work; HZ,SZ,YX: acquisition, analysis, and interpretation of the data; HZ: drafting of the manuscript; TF: revising the manuscript critically. All authors have read and approved the final article.

Corresponding author

Correspondence to Tianyou Fan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, H., Li, Y., Xie, X. et al. Efficacy of Local Control Strategies for Ewing Sarcoma After Neoadjuvant Chemotherapy: A Network Meta-analysis. Indian Pediatr 57, 527–532 (2020). https://doi.org/10.1007/s13312-020-1850-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-020-1850-6

Keywords

Navigation